For the month ended 31 July 2026, Lung Fung Group Holdings Limited reported no movements in either authorised or issued share capital, according to its monthly return filed with Hong Kong Exchanges and Clearing Limited on 3 August 2026.
The company’s authorised share capital remained at 3.90 billion ordinary shares with a par value of HKD 0.0001 each, equivalent to HKD 390,000. Issued share capital also held steady at 500.00 million ordinary shares, with no treasury shares outstanding.
Lung Fung confirmed full compliance with the Main Board’s minimum public-float requirement of 25% of issued shares. During July, the group executed no share option grants, warrant issuances, convertible securities, share repurchases, or other equity transactions.
All requisite confirmations under Main Board Rule 13.25C were provided by Company Secretary Lam Yin Ling, affirming that statutory and listing-rule obligations remain satisfied.
Comments